Tenofovir is a reverse-transcriptase inhibitor based on acyclic nucleotide analogs. Tenofovir
is a drug that is often used in treating HIV infection and has also been approved for treating …

Tenofovir is a nucleotide reverse transcriptase inhibitor used as part of antiretroviral
regimens. It is well tolerated with relative toxicological effects but recent reports have linked …

Tenofovir is one of the most commonly used antiretrovirals in adolescents and adults
because of its potency and favorable pharmacokinetic and relative safety toxicological …

Tenofovir is an acyclic nucleotide analogue reverse‐transcriptase inhibitor structurally
similar to the nephrotoxic drugs adefovir and cidofovir. Tenofovir is widely used to treat HIV …

Tenofovir Disoproxil Fumarate (TDF) is the first nucleotide analog approved for human
immunodeficiency virus 1 (HIV-1) treatment. It is a prodrug of tenofovir. High-fat meals may …

Objective In this study, data regarding epidemiology, risk factors, pathogenesis and outcome
of tenofovir-induced nephrotoxicity will be reviewed, and current and future approaches for …

Importance of the field: Tenofovir (TFV) is a nucleotide analogue widely used for the
treatment of HIV infection. Despite its proven efficacy and safety, cases of kidney tubular …

The use of the antiretroviral drug tenofovir has been associated with nephrotoxicity.
However, the overall impact of this adverse effect has not been comprehensively evaluated …

Tenofovir (TFV) is a reverse transcriptase inhibitor that is approved by the United States
Food and Drug Administration (FDA) to treat HIV and chronic Hepatitis B. It has a long half …

Background Tenofovir (TDF) has been associated with renal function deterioration, but local
data regarding the incidence and risk factors for this adverse event were lacking. Objectives …